Solution
= Solution
Recent innovations offered plausible routes to better outcomes for <delusions> by replacing a broad, undifferentiated treatment target with specific maintaining processes. Persistent persecutory <beliefs> may be supported by <worry>, poor sleep, felt vulnerability, low confidence, reasoning inflexibility and <safety behaviors>. Changing one of these may create opportunities for a person to reconsider threat without demanding immediate agreement that their <belief> is wrong. The promise is mechanistic and practical; it does not imply that all <delusions> share one cause or that every plausible target will improve <clinical outcomes>.
A contributory-causal approach begins by identifying a potentially modifiable process, experimentally changing it and examining consequences for the clinical problem. <Worry> is an example: repeated anticipation of danger can generate threatening explanations and keep them mentally available. In the <Worry Intervention Trial>, <Daniel Freeman> and colleagues <Randomization>[randomised] 150 patients with persistent <persecutory delusions> to six sessions targeting <worry> alongside standard care, or standard care alone. <Worry> and <delusion> outcomes improved, with gains followed to 24 weeks. Because therapist contact was not matched, the result supports the added intervention package more securely than an exclusively worry-mediated effect.<Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis by Daniel Freeman and others>[Lancet Psychiatry 2, 305–313; 150 patients, six worry sessions plus usual care versus usual care, eight-/24-week outcomes]{ref}
Sleep offers a different entry point that may be more acceptable than directly debating a threat <belief>. The OASIS trial <Randomization>[randomised] 3755 university students with insomnia to digital <CBT> for sleep or usual practice. It produced a large sleep benefit and smaller changes in <paranoia> and hallucinatory experiences. This supports testing sleep as a contributory process, while the nonclinical student sample and usual-practice comparator prevent direct inference that the same intervention treats persistent <delusions> in patients with <psychosis>.<The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis by Daniel Freeman and others>[Lancet Psychiatry 4, 749–758; 3755 university students with insomnia, digital CBT versus usual practice and population limits]{ref}
The <Feeling Safe Programme> combined individually selected modules addressing relevant maintaining factors. Its 2021 trial allocated 130 patients with persistent <persecutory delusions> to Feeling Safe or same-therapist befriending, with usual care continuing. The six-month adjusted difference in <delusional conviction> favoured Feeling Safe by about 10.7 points on a 0–100 scale. A categorical <Clinical recovery>[recovery] comparison was less precise and did not reach conventional significance. The positive continuous <primary outcome> therefore should not be restated as a definitively superior <Clinical recovery>[recovery] rate.<Comparison of a theoretically driven cognitive therapy (the Feeling Safe Programme) with befriending for the treatment of persistent persecutory delusions: a parallel, single-blind, randomised controlled trial by Daniel Freeman and others>[Lancet Psychiatry 8, 696–707; 130 patients, same-therapist befriending, six-month continuous conviction and categorical recovery distinction]{ref}
Reasoning interventions aim to increase flexibility and slow hasty acceptance of threatening explanations. <Philippa Garety> and colleagues' <SlowMo> combined eight face-to-face sessions, digital material and a mobile application. In the 361-person analysis, the primary total <paranoia> score at 24 weeks did not show a statistically significant advantage over usual care, although several secondary and earlier outcomes favoured the intervention. There was no significant effect on <jumping to conclusions>. This mixed pattern is particularly important: an engaging, mechanistically informed treatment can show promising signals without meeting its prespecified primary test.<Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis: A Randomized Clinical Trial by Philippa Garety and others>[JAMA Psychiatry 78, 714–725; 361 in analysis, prespecified 24-week GPTS total endpoint and secondary outcomes]{ref}
These approaches could improve outcomes for several reasons. Targeting common difficulties such as insomnia or <worry> can give treatment an understandable starting point. Personalised modules can concentrate time on processes actually present instead of requiring every patient to complete the same sequence. Concrete experiments may provide more persuasive evidence than verbal reassurance. Digital support can make an exercise accessible between appointments, while carefully designed measures can show whether the nominated process changed before the <belief> or <distress> changed.
However, a target can be associated with <delusions> without causing them. Poor sleep and <worry> may partly reflect a common adversity, or lessen when general <distress> improves. An intervention intended for one process can alter several others, making a statistical <Causal mediator>[mediator] an uncertain guide to the active ingredient. Even when a factor contributes causally, changing it may produce only modest benefit because other maintaining processes remain. Necessary theoretical precision includes specifying who has the target, how much it must change and which outcome should follow.
Outcome choice can make an innovation appear more or less successful. Conviction, preoccupation, <distress>, activity, quality of life and diagnostic status are related but distinct. Greater doubt about a threatening explanation may be valuable without elimination of the <belief>; conversely, a questionnaire change need not restore work or social participation. The difference between <SlowMo>'s primary and secondary findings illustrates why the endpoint and assessment time should be specified in advance. Multiple favourable secondary results cannot simply replace an unsuccessful primary test.
Clinical heterogeneity also matters. A treatment developed for persistent <persecutory delusions> is not automatically established for every delusional theme, acute state or diagnostic group. Language requirements, willingness to attend research therapy and referral patterns select who enters a trial. Comorbid <depression>, cognitive difficulties, substance use or continuing victimisation may alter the usefulness of a module. An unusual <belief> should be assessed in its cultural and social context; a psychological account must not assume that all reported threats are unreal.
Innovations can fail at implementation even when the trial mechanism is sound. Skilled research therapists, close supervision and protected time may be unavailable in routine services. A mobile application can increase opportunity for practice but also introduce access, privacy or comprehension barriers. Adding modules can increase burden, dilute effective content or delay the experiment that matters most. Patients may prefer a different target from the one selected by a questionnaire. <Treatment acceptability>[Acceptability], <Treatment fidelity>[fidelity], reach and cost therefore need direct measurement alongside <symptom> outcomes.
A strong next study would compare an adapted innovation with a credible active treatment in several services, with adequate <Statistical power>[power] and <Blinding>[blinded] assessment. Prespecify primary conviction or <distress> outcomes, patient-prioritised functioning and longer-term maintenance. Measure candidate mechanisms repeatedly, recording which modules are actually received; module choice in a tailored treatment is not random and cannot itself identify the best component. A complementary factorial or sequentially <Randomization>[randomised] experiment could test specific additions while preserving adequate care for all participants.
By May 2022, the most convincing advance was the shift toward testable mechanisms and more rigorous, symptom-focused clinical comparisons. <Worry>, sleep, flexible reasoning and personalised threat-learning approaches offered reasons for optimism, with some positive clinical results and important null findings. Better outcomes would depend on genuine <target engagement>, adequate comparisons, generalisation and feasible delivery, rather than novelty, a digital format or a plausible causal diagram alone.